All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-21663632
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21663632 A98A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
2 21663632 A98G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
3 21663632 A98S
RT
gag-pol
HIV Infections
D
G
C
L
T
View
4 21663632 D67G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
5 21663632 D67N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
6 21663632 G190A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
7 21663632 G190G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
8 21663632 G190S
RT
gag-pol
HIV Infections
D
G
C
L
T
View
9 21663632 H221H
RT
gag-pol
HIV Infections
D
G
C
L
T
View
10 21663632 H221Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
11 21663632 K101E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
12 21663632 K103K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
13 21663632 K103N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
14 21663632 K219E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
15 21663632 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
T
View
16 21663632 K219R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
17 21663632 K65R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
18 21663632 K70R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
19 21663632 L210W
RT
gag-pol
HIV Infections
D
G
C
L
T
View
20 21663632 M184I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
21 21663632 M184M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
22 21663632 M184V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
23 21663632 M41L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
24 21663632 M41M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
25 21663632 Q151M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
26 21663632 T215F
RT
gag-pol
HIV Infections
D
G
C
L
T
View
27 21663632 T215N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
28 21663632 T215S
RT
gag-pol
HIV Infections
D
G
C
L
T
View
29 21663632 T215T
RT
gag-pol
HIV Infections
D
G
C
L
T
View
30 21663632 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
31 21663632 T69D
RT
gag-pol
HIV Infections
D
G
C
L
T
View
32 21663632 T69N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
33 21663632 T69S
RT
gag-pol
HIV Infections
D
G
C
L
T
View
34 21663632 V106A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
35 21663632 V106M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
36 21663632 V75M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
37 21663632 V75V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
38 21663632 V90I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
39 21663632 V90V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
40 21663632 Y181C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
41 21663632 Y181V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
42 21663632 Y181Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
43 21663632 Y188C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
44 21663632 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.